Skip to main content
. 2019 Nov 20;367:l6132. doi: 10.1136/bmj.l6132

Table 3.

Correlation assessment between primary outcome and key blood parameters and platelet and growth factor properties in samples of platelet rich plasma

Key blood parameters and platelet properties No r Variance (%)* P value
Blood cell counts
Erythrocyte count 91 0.13 1.59 0.23
Leucocyte count 91 −0.10 1.05 0.33
Platelet count† 88 0.13 1.65 0.23
Platelet quality (resting)
Resting CD62p expression (%) 93 0.10 0.92 0.75
Mean fluorescence intensity 94 −0.03 0.07 0.97
Platelet quality (activated)
Activated CD62p expression (%) 92 0.04 0.14 0.72
Mean fluorescence intensity 92 <−0.01 <0.01 0.97
Growth factors
Insulin-like growth factor 1 93 0.12 1.25 0.29
Transforming growth factor β1 88 0.01 <0.01 0.96
Platelet derived growth factor-AB 90 <0.01 <0.01 1.00
Vascular endothelial growth factor 93 −0.23 5.35 0.03
Fibroblast growth factor-basic 93 −0.10 1.05 0.33

CD62p=P selectin.

*

Proportion of variance in work limb symmetry index explained by blood parameter.

As fluorescent platelet count.